摘要
目的研究手术联合米非司酮治疗子宫内膜异位症(内异症)的临床效果及应用可行性。方法选择本院内异征患者76例,随机分为单纯手术组(对照组)例与手术联合米非司酮治疗组,观察其疗效。结果术后3个月时,米非司酮组痛经、非经期下腹痛、性交痛、子宫直肠窝结节、结节触痛和子宫活动受限的缓解率分别为100%、85.7%、90.0%、85.1%、89.2%和100.0%,对照组分别为64.2%、33.3%、55.6%、33.3%、50.0%和50.0%。2组比较,用药组的征状、体征改善情况明显优于对照组(P<0.05)。结论内异症术后术后加用米非司酮可廷长征状暖解时间,复发率低,妊娠率高,故术后加用米非司酮是治疗内异症的较好途径。
Objective To study the etticacy and safety continuouslys surgical operation consociation mifepristone used for endometriosis. Methods 61patients with endometriosis were randomly classificed into surgical operation group(control group) and surgical operation consociation mifepristone group(study group).All patients were followed for 3 months,identified the effficacy. Results In study group the remission rate of dysmemorrhe, pain in the lower abdomen before and after menstruation,pain during sexual intercourse,nodus in rectouterine pouch,tender nudus and uterus movement limited were 100%,85.7%,90.0%,85.1%,89.2%和100.0%.In control group they were 64.2%,33.3%,55.6%,33.3%,50.0%和50.0%. The remission rates were significanty higher in study group than in control group(P<0.05).Conclusion Surgical operation consociaion mifepristone can prolong the symptoms remission time,reduce recurrence rate and increase the rate of subsequent pregnancy.
出处
《中国实用医药》
2007年第15期91-93,共3页
China Practical Medicine
关键词
手术
子宫内膜异位症
米非司酮
surgical operation
endometriosis
mifepristone
